Skip to content

Thursday, May 8, 2025

Latest:

FROM THE LABS: A combined computational and experimental approach uncovered promising genetic players in Alzheimer’s disease
Healthy Habits: Group workouts motivate Dr. Jordana Faruqi
Facing heart surgery? Here’s what you should know
Image of the Month: A closer look at metastatic medulloblastoma
The importance of nurses goes beyond seeing patients in clinics

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

cisplatin

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951